Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -42,688 | -22,738 | -71,584 | -52,214 | -31,445 |
| Depreciation Amortization | -1,107 | -582 | -4,306 | -2,596 | -690 |
| Accounts payable and accrued liabilities | 551 | 2,155 | -2,250 | -1,289 | 304 |
| Other Working Capital | -9,019 | -4,635 | 1,401 | -4,063 | -7,215 |
| Other Operating Activity | 8,467 | 2,439 | 15,470 | 11,375 | 6,153 |
| Operating Cash Flow | $-43,796 | $-23,361 | $-61,269 | $-48,787 | $-32,893 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -61,528 | -17,865 | -148,263 | -186,963 | -151,430 |
| PPE Investments | -22 | -20 | -149 | -135 | -119 |
| Other Investing Activity | 10,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-51,550 | $-17,885 | $-148,412 | $-187,098 | $-151,549 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 92,076 | 90,270 | 399 | 309 | 281 |
| Other Financing Activity | 0 | 0 | 233,887 | 233,887 | 234,340 |
| Financing Cash Flow | $92,076 | $90,270 | $234,286 | $234,196 | $234,621 |
| Beginning Cash Position | 100,195 | 100,195 | 75,590 | 75,590 | 75,590 |
| End Cash Position | 96,925 | 149,219 | 100,195 | 73,901 | 125,769 |
| Net Cash Flow | $-3,270 | $49,024 | $24,605 | $-1,689 | $50,179 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,796 | -23,361 | -61,269 | -48,787 | -32,893 |
| Capital Expenditure | -22 | -20 | -149 | -135 | -119 |
| Free Cash Flow | -43,818 | -23,381 | -61,418 | -48,922 | -33,012 |